PortfoliosLab logoPortfoliosLab logo

Delaware Healthcare Fund (DLHIX) Alternatives

Delaware Healthcare Fund (DLHIX) belongs to the Health & Biotech Equities category. Below you'll find alternative mutual funds from the same category, ranked by key criteria, plus funds that investors commonly compare with DLHIX. Use the tables to find lower-cost options, better risk-adjusted returns, or funds that fit a different role in your portfolio.

Cheapest Alternatives to DLHIX

DLHIX charges 0.98% annually. Among mutual funds in the Health & Biotech Equities category, these options have the lowest expense ratios among DLHIX alternatives.


Best Risk-Adjusted Alternatives to DLHIX

Among mutual funds in the Health & Biotech Equities category, these options rank highest on PortfoliosLab's risk-adjusted score, which accounts for volatility, drawdown, and return consistency over a 1-year period.


Top Performing DLHIX Alternatives (YTD)

DLHIX alternatives from the Health & Biotech Equities category, sorted by year-to-date return.


Lowest Volatility Alternatives to DLHIX

DLHIX alternatives from the Health & Biotech Equities category, sorted by annualized volatility over the past year.


Lowest Drawdown Alternatives to DLHIX

DLHIX alternatives from the Health & Biotech Equities category, sorted by maximum drawdown over the past year.


Other Mutual Funds from Delaware Funds by Macquarie

Most popular Delaware Funds by Macquarie mutual funds on PortfoliosLab, across asset classes.


Often Compared With DLHIX

What investors most often compare with DLHIX, based on PortfoliosLab usage data.


Compare DLHIX with Any Fund or Stock

Compare DLHIX with any ETF, mutual fund, or stock using PortfoliosLab's comparison tool.


Delaware Healthcare Fund